Latest News
Intel Stock's October Was Its Worst Month Since at Least 1980. History Says What Can Come Next.fool.com
The chipmaker's other worst months brought both deeper drops and strong rallies. Which one looks most like today?
Via The Motley Fool · November 3, 2026
Amazon Thinks AWS Could Become a $1 Trillion Business. Here's Why.fool.com
CEO Andy Jassy believes Amazon Web Services' opportunity goes well beyond AI.
Via The Motley Fool · November 3, 2026
Paymentus (PAY) Q3 2026 Earnings Call Transcriptfool.com
Record Q3 results and raised full-year guidance across all metrics.
Via The Motley Fool · November 3, 2026
Lattice (LSCC) Q3 2026 Earnings Call Transcriptfool.com
Record Q3 results driven by data center AI momentum and industrial market recovery.
Via The Motley Fool · November 3, 2026
Vertex (VRTX) Q3 2026 Earnings Call Transcriptfool.com
Revenue grew 12% as newer products like CASGEVY and JOURNAVX ramped up significantly.
Via The Motley Fool · November 3, 2026
Kimberly-Clark Acquires Kenvue. Here’s What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.fool.com
The enterprise value of the monster deal was estimated at almost $49 billion.
Via The Motley Fool · November 3, 2026
2 Unstoppable Quantum Computing Stocks to Buy Hand Over Fist Before the Next Rallyfool.com
IonQ's revenue rose 287% and Rigetti's 185% last quarter, but both carry steep valuations. Here's how the two compare on risk and fit.
Via The Motley Fool · November 3, 2026
Palantir: 3 Key Takeaways for Long-Term Investorsfool.com
The company's shift to enterprise workflows over generic productivity tools reveals why its pricing power may compound as corporate adoption accelerates.
Via The Motley Fool · November 3, 2026
Kosmos Energy (KOS) Q3 2026 Earnings Call Transcriptfool.com
Production grew 6% as debt fell $500 million, signaling improved momentum.
Via The Motley Fool · November 3, 2026
JAZZ Q3 deep dive: oncology momentum and new launches offset margin pressure
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) beat Wall Street’s revenue expectations in Q3 2026, with sales up 10.4% year on year to $1.24 billion. T...
Via StockStory · November 3, 2026
FOXA Q3 deep dive: Sports, Tubi, and FOX One drive growth amid evolving media landscape
Cable news and media network Fox (NASDAQ:FOXA) reported revenue ahead of Wall Street’s expectations in calendar Q3 2026 (fiscal Q1 2027), with sales up 22.3%...
Via StockStory · November 3, 2026
EVER Q3 deep dive: AI-driven growth and new product launches expand addressable market
Online insurance comparison site EverQuote (NASDAQ:EVER) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 25.4% year on year to...
Via StockStory · November 3, 2026
OPAD Q3 deep dive: mortgage rate volatility and operational shifts drive cautious outlook
Technology real estate company Offerpad (NYSE:OPAD) fell short of the market’s revenue expectations in Q3 2026, with sales falling 41.2% year on year to $78....
Via StockStory · November 3, 2026
LSCC Q3 deep dive: AI-driven demand and new product launches fuel broad-based growth
Semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) announced better-than-expected revenue in Q3 2026, with sales up 118% year on year to $291 million...
Via StockStory · November 3, 2026
PLTR Q3 deep dive: U.S. commercial outpaces government as Sovereign AI drives adoption
Data analytics company Palantir Technologies (NASDAQ:PLTR) reported Q3 2026 results topping the market’s revenue expectations, with sales up 95.9% year on ye...
Via StockStory · November 3, 2026
KOS Q3 deep dive: cost discipline and debt reduction offset by production headwinds
Oil and gas producer Kosmos Energy (NYSE:KOS) missed Wall Street’s revenue expectations in Q3 2026, but sales rose 31.8% year on year to $410.2 million. Its ...
Via StockStory · November 3, 2026
MAR Q3 deep dive: leisure travel, conversions, and tech investment drive guidance boost
Global hospitality company Marriott (NASDAQ:MAR) announced better-than-expected revenue in Q3 2026, with sales up 8% year on year to $7.01 billion. Its non-G...
Via StockStory · November 3, 2026
BWXT Q3 deep dive: nuclear growth pipeline advances despite revenue miss
Aerospace and defense company BWX (NYSE:BWXT) fell short of the market’s revenue expectations in Q3 2026, but sales rose 10% year on year to $953 million. On...
Via StockStory · November 3, 2026
PAY Q3 deep dive: platform expansion and interchange monetization drive Paymentus momentum
Digital payment platform Paymentus (NYSE:PAY) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 19.8% year on year to $372.2...
Via StockStory · November 3, 2026
BMRN Q3 deep dive: pipeline expansion and order timing weigh on guidance
Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) met Wall Street’s revenue expectations in Q3 2026, with sales up 32% year on year to $1.02 billion. On ...
Via StockStory · November 3, 2026
AEIS Q3 deep dive: manufacturing expansions and new product momentum drive robust growth
Manufacturing equipment and systems provider Advanced Energy (NASDAQ:AEIS) beat Wall Street’s revenue expectations in Q3 2026, with sales up 50.3% year on ye...
Via StockStory · November 3, 2026
EL Q3 deep dive: fragrance and innovation drive broad-based growth, margin recovery continues
Beauty products company Estée Lauder (NYSE:EL) reported calendar Q3 2026 (fiscal Q1 2027) results beating Wall Street’s revenue expectations, with sales up 6...
Via StockStory · November 3, 2026
CLX Q3 deep dive: productivity gains and strategic pricing drive margin recovery amid cost pressures
Consumer products giant Clorox (NYSE:CLX) beat Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q1 2027), with sales up 33.3% year on year to $...
Via StockStory · November 3, 2026
VRTX Q3 deep dive: Pipeline, product launches, and Crinetics integration shape outlook
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 11.8% year on year t...
Via StockStory · November 3, 2026
Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcriptfool.com
Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.
Via The Motley Fool · November 3, 2026
